Jubilant Pharmova’s arm enters into loan agreement with Standard Chartered Bank

14 Jul 2022 Evaluate

Jubilant Pharmova’s step down subsidiary -- Jubilant Pharma Holdings Inc (JPHI) has entered into loan agreement with Standard Chartered Bank. The agreement is for five year loan facility for repayment of existing term loan and bonds aggregating $350 million and additional tranche of $50 million for future growth capex.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×